Efficacy of platinum-based chemotherapy in platinum-resistant ovarian cancer: A systematic review with pooled analysis of outcomes.

被引：0
|
作者：
Rumyantsev, Alexey
Tyulyandina, Alexandra
Fedyanin, Mikhail
Pokataev, Ilya
Glazkova, Elena
Nikulin, Vladislav
Tjulandin, Sergei
机构：
[1] Minist Hlth Russian Federat NN Blokhin NMRCO, Fed State Budgetary Inst, NN Blokhin Natl Med Res Ctr Oncol, Moscow, Russia
[2] NN Blokhin Natl Med Res Ctr Oncol, St Petersburg, Russia
[3] NN Blokhin Natl Med Res Ctr Oncol, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18076
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mirvetuximab soravtansine superior to chemotherapy in platinum-resistant epithelial ovarian cancer
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (02) : 83 - 83
  • [22] Salvage chemotherapy with paclitaxel in platinum-resistant advanced ovarian cancer patients
    Bruzzone, M
    Catsafados, E
    Miglietta, L
    Amoroso, D
    Pedulla, F
    Giannessi, PG
    Locatelli, MC
    DAntona, A
    Foglia, G
    Mammoliti, S
    Turno, F
    Gentile, A
    Nicosia, F
    Luporini, G
    Ragni, N
    Boccardo, F
    ONCOLOGY, 1996, 53 (05) : 349 - 353
  • [23] Antitumor Effect of Nivolumab on Subsequent Chemotherapy for Platinum-Resistant Ovarian Cancer
    Inayama, Yoshihide
    Hamanishi, Junzo
    Matsumura, Noriomi
    Murakami, Ryusuke
    Abiko, Kaoru
    Yamaguchi, Ken
    Baba, Tsukasa
    Horie, Katsuyuki
    Konishi, Ikuo
    Mandai, Masaki
    ONCOLOGIST, 2018, 23 (11): : 1382 - 1384
  • [24] Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer
    Markman, Maurie
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 273 - 274
  • [25] NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancer
    Konrad, Sarah M.
    Schwamborn, Kristina
    Krueger, Achim
    Honert, Katja
    Schmitt, Manfred
    Hellmann, Daniela
    Schmalfeldt, Barbara
    Meindl, Alfons
    Kiechle, Marion
    Quante, Anne S.
    Brambs, Christine
    Grill, Sabine
    Ramser, Juliane
    BIOMARKERS IN MEDICINE, 2022, 16 (14) : 1029 - 1041
  • [26] SCREENING AND IDENTIFICATION OF NOVEL CHEMOTHERAPY AGENTS IN PLATINUM-RESISTANT OVARIAN CANCER
    Schweer, D.
    Mccorkle, J.
    Rohr, J.
    Tsodikov, O.
    Ueland, F.
    Kolesar, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A29 - A30
  • [27] Real-world outcomes associated with bevacizumab combined with chemotherapy in platinum-resistant ovarian Cancer
    Moffat, Gordon Taylor
    Kong, Weidong
    MacKay, Helen J.
    McGee, Jacob
    Booth, Christopher M.
    Ethier, Josee-Lyne
    GYNECOLOGIC ONCOLOGY, 2024, 184 : 51 - 56
  • [28] Gemcitabine and anthracyclines in platinum-resistant ovarian cancer
    Galligioni, E.
    Arcuri, C.
    Sorio, R.
    Griso, C.
    ANNALS OF ONCOLOGY, 2006, 17 : V195 - V198
  • [29] Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
    Afifah, Nadiya Nurul
    Diantini, Ajeng
    Intania, Ruri
    Abdulah, Rizky
    Barliana, Melisa, I
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 : 427 - 444
  • [30] Mirvetuximab Soravtansine for platinum-resistant Ovarian Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (08) : 882 - 882
12345